574 related articles for article (PubMed ID: 26592251)
21. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
[TBL] [Abstract][Full Text] [Related]
22. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of protection by the betaine-homocysteine methyltransferase/betaine system in HepG2 cells and primary mouse hepatocytes.
Ji C; Shinohara M; Kuhlenkamp J; Chan C; Kaplowitz N
Hepatology; 2007 Nov; 46(5):1586-96. PubMed ID: 17705221
[TBL] [Abstract][Full Text] [Related]
24. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
25. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
26. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
Chen XQ; He JR; Wang HY
Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
[TBL] [Abstract][Full Text] [Related]
29. Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas.
Teng YW; Mehedint MG; Garrow TA; Zeisel SH
J Biol Chem; 2011 Oct; 286(42):36258-67. PubMed ID: 21878621
[TBL] [Abstract][Full Text] [Related]
30. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype.
Lin Y; Lin G; Fang W; Zhu H; Chu K
Med Oncol; 2014 Dec; 31(12):327. PubMed ID: 25412936
[TBL] [Abstract][Full Text] [Related]
32. Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma.
Xu K; Gao J; Yang X; Yao Y; Liu Q
Oncol Rep; 2013 Jun; 29(6):2211-8. PubMed ID: 23545718
[TBL] [Abstract][Full Text] [Related]
33. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
34. Low expression of B-cell-associated protein 31 in human primary hepatocellular carcinoma correlates with poor prognosis.
Tan N; Liu Q; Liu X; Gong Z; Zeng Y; Pan G; Xu Q; He S
Histopathology; 2016 Jan; 68(2):221-9. PubMed ID: 25980696
[TBL] [Abstract][Full Text] [Related]
35. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
[TBL] [Abstract][Full Text] [Related]
36. Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.
Wang JH; Wei W; Xu J; Guo ZX; Xiao CZ; Zhang YF; Jian PE; Wu XL; Shi M; Guo RP
Oncotarget; 2015 Oct; 6(33):35116-28. PubMed ID: 26375669
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
38. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
39. CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.
Liu F; Lv H; Jia X; Liu G; Li T; Xu Z; Li J
J Surg Oncol; 2014 Aug; 110(2):151-5. PubMed ID: 24634224
[TBL] [Abstract][Full Text] [Related]
40. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection.
Liu W; Wang N; Lu M; Du XJ; Xing BC
Mol Med Rep; 2016 Aug; 14(2):1617-23. PubMed ID: 27315121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
